Today, most drug companies offer large rebates to pharmacy benefit managers on behalf of different health plans and employers to reduce patients’ out-of-pocket costs. The problem is a significant portion of the savings is not being passed onto the public.
Continue reading Who Is Getting Rich from the Price of Prescription Drugs?
The audience was aghast to learn that a specialty drug for Hep.C. earned PBM’s a 45% commission for one course of treatment………..
Continue reading PBM Exposes Industry Secrets on Specialty Drugs
Pascal Metrics is the field leader in measuring and improving patient safety through advanced Patient Safety Analytics (PSA).
Continue reading Pascal Metrics Provides Patient Safety Analytics